FFAR3 and diabetes mellitus: We therefore conclude that "gut microbiota – SCFAs – GPR41/43" is involved in the pathological process of T2DM, and this finding may provide a new strategy for the treatment of diabetes and a new direction for the research and development of new hypoglycemic drugs.